Patents Assigned to Novo Nordis Biotech, Inc.
  • Patent number: 6033892
    Abstract: The present invention relates to isolated polypeptides having 5-aminolevulinic acid synthase activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing and using the polypeptides.
    Type: Grant
    Filed: November 16, 1998
    Date of Patent: March 7, 2000
    Assignee: Novo Nordis Biotech, Inc.
    Inventor: Greg Gambetta